INO stock forecast
Our latest prediction for Inovio Pharmaceuticals, Inc.'s stock price was made on the Jan. 13, 2020 when the stock price was at 3.35$.
In the short term (2weeks), INO's stock price should underperform the market by -0.49%. During that period the price should oscillate between -10.17% and +14.45%.
In the medium term (3months), INO's stock price should underperform the market by -12.09%. During that period the price should oscillate between -43.92% and +30.61%.Get email alerts
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a loss of -1.18$ per share.
The book value per share is 1.22$
Three months stock forecastJan. 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|